Page 4 - Part-1
P. 4
COVER STORY COVER STORY COVER STORY
The Nephrocare division of the
The Nephrocare division of the However, this revamp will equip the company to match The Nephrocare division of the
its aggressive growth plan and enable it to introduce an
F1 plant caters to the
F1 plant caters to the innovative range of products that will sustain its F1 plant caters to the
management of chronic kidney
management of chronic kidney competitiveness. Additionally, the upgraded facility will management of chronic kidney
help the company meet international regulatory
disease. The division has some The division has some
disease. The division has some standards, opening up several global market disease.
opportunities.
landmark brands that have
landmark brands that have landmark brands that have
revolutionised nephrocare. The formulations produced here are used for a wide revolutionised nephrocare.
revolutionised nephrocare.
range of maladies, ranging from edema and diarrhoea to
Today, as per ORG-IMS, the cardiovascular diseases and schizophrenia. The F1 T
Today, as per ORG-IMS, the oday, as per ORG-IMS, the
facility is responsible for rolling out several of RPG Life
company’
company’s Nephrocare division Sciences’ marquee products, including Aldactone, company’s Nephrocare division s Nephrocare division
has been ranked number 1 in Lomofen and Naprosyn. It manufactures has been ranked number 1 in
has been ranked number 1 in
immunosuppressants such as Azoran and Mofetyl,
this therapeutic area. Upgrading
this therapeutic area. Upgrading which are used for preventing organ rejection during this therapeutic area. Upgrading
kidney transplants, and antipsychotics such as Serenace
the plant systems and related and Sizomax. Other major products include Rabee and the plant systems and related
the plant systems and related
process protocols will help RPG
process protocols will help RPG Spiromide, which are used to treat gastric ulcers and process protocols will help RPG
edema respectively.
Life Sciences retain this
Life Sciences retain this Life Sciences retain this
leadership position. leadership position.
leadership position.
4 4 4
